Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Shares, (euro)0.09 nominal value per share
-
Shares outstanding
-
75.4M
-
Number of holders
-
103
-
Total 13F shares, excl. options
-
33M
-
Shares change
-
+9.68M
-
Total reported value, excl. options
-
$1.05B
-
Value change
-
+$313M
-
Number of buys
-
63
-
Number of sells
-
-26
-
Price
-
$31.80
Significant Holders of Merus N.V. - Common Shares, (euro)0.09 nominal value per share (MRUS) as of Q4 2021
108 filings reported holding MRUS - Merus N.V. - Common Shares, (euro)0.09 nominal value per share as of Q4 2021.
Merus N.V. - Common Shares, (euro)0.09 nominal value per share (MRUS) has 103 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33M shares
of 75.4M outstanding shares and own 43.77% of the company stock.
Largest 10 shareholders include BVF INC/IL (4.14M shares), FEDERATED HERMES, INC. (3.68M shares), WELLINGTON MANAGEMENT GROUP LLP (3.15M shares), BAKER BROS. ADVISORS LP (2.04M shares), BOXER CAPITAL, LLC (1.9M shares), Medicxi Ventures Management (Jersey) Ltd (1.6M shares), COMMODORE CAPITAL LP (1.5M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (1.1M shares), BIOIMPACT CAPITAL LLC (927K shares), and Aquilo Capital Management, LLC (897K shares).
This table shows the top 103 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.